In this image taken from NASA video, NASA astronauts Kate Rubins, top, and Victor Glover work outside the International Space Station Sunday, Feb. 28, 2021. Thespacewalking astronauts ventured out Sunday to install support frames for new, high-efficiency solar panels arriving at the International Space Station later this year. (NASA via AP)
By Marcia Dunn
Spacewalking astronauts ventured out Sunday to install support frames for new, high-efficiency solar panels arriving at the International Space Station later this year.
NASA's Kate Rubins and Victor Glover put the first set of mounting brackets and struts together, then bolted them into place next to the station's oldest and most degraded solar wings. But the work took longer than expected, and they barely got started on the second set before calling it quits.
Rubins will finish the job during a second spacewalk later this week.
The spacewalkers had to lug out the hundreds of pounds of mounting brackets and struts in 8-foot (2.5-meter) duffle-style bags. The equipment was so big and awkward that it had to be taken apart like furniture, just to get through the hatch.
Some of the attachment locations required extra turns of the power drill and still weren't snug enough, as indicated by black lines. The astronauts had to use a ratchet wrench to deal with the more stubborn bolts, which slowed them down. At one point, they were two hours behind.
“Whoever painted this black line painted outside the lines a little bit," Glover said at one particularly troublesome spot.
“We’ll work on our kindergarten skills over here,” Mission Control replied, urging him to move on.
With more people and experiments flying on the space station, more power will be needed to keep everything running, according to NASA. The six new solar panels — to be delivered in pairs by SpaceX over the coming year or so — should boost the station’s electrical capability by as much as 30%.
Rubins and Glover tackled the struts for the first two solar panels, due to launch in June. Their spacewalk ended up lasting seven hours, a bit longer than planned.
“Really appreciate your hard work. I know there were a lot of challenges,” Mission Control radioed.
The eight solar panels up there now are 12 to 20 years old — most of them past their design lifetime and deteriorating. Each panel is 112 feet (34 meters) long by 39 feet (12 meters) wide. Tip to tip counting the center framework, each pair stretches 240 feet (73 meters), longer than a Boeing 777′s wingspan.
Boeing is supplying the new roll-up panels, about half the size of the old ones but just as powerful thanks to the latest solar cell technology. They’ll be placed at an angle above the old ones, which will continue to operate.
A prototype was tested at the space station in 2017.
Rubins' helmet featured a new high-definition camera that provided stunning views, particularly those showing the vivid blue Earth 270 miles (435 kilometers) below. “Pretty fantastic," observed Mission Control.
Sunday’s spacewalk was the third for infectious disease specialist Rubins and Navy pilot Glover — both of whom could end up flying to the moon.
They’re among 18 astronauts newly assigned to NASA’s Artemis moon-landing program. The next moonwalkers will come from this group.
Last week, Vice President Kamala Harris put in a congratulatory call to Glover, the first African American astronaut to live full time at the space station. NASA released the video exchange Saturday.
“The history making that you are doing, we are so proud of you,” Harris said. Like other firsts, Glover replied, it won't be the last. “We want to make sure that we can continue to do new things,” he said.
Rubins will float back out Friday with Japanese astronaut Soichi Noguchi to wrap up the solar panel prep work, and to vent and relocate ammonia coolant hoses.
Glover and Noguchi were among four astronauts arriving via SpaceX in November. Rubins launched from Kazakhstan in October alongside two Russians. They’re all scheduled to return to Earth this spring.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
